(Q35171866)

English

Angiotensin II dose-effect curves and Schild regression plots for characterization of different angiotensin II AT1 receptor antagonists in clinical pharmacology

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

1 reference

Europe PubMed Central

Angiotensin II dose-effect curves and Schild regression plots for characterization of different angiotensin II AT1 receptor antagonists in clinical pharmacology (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

author name string

Gustav G Belz

1

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

language of work or name

0 references

publication date

1 July 2003

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

British Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

56

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

3-10

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

pA, a new scale for the measurement of drug antagonism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884329

13 July 2018

Some quantitative uses of drug antagonists

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884329

13 July 2018

A modification of receptor theory

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884329

13 July 2018

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884329

13 July 2018

Heinz Otto Schild, 18 May 1906 - 15 June 1984

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884329

13 July 2018

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884329

13 July 2018

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884329

13 July 2018

Comparison of angiotensin II receptor antagonists

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884329

13 July 2018

Angiotensin II receptor antagonists

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884329

13 July 2018

Angiotensin II receptor blockade in normotensive subjects: A direct comparison of three AT1 receptor antagonists

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884329

13 July 2018

Binding of the antagonist [3H]candesartan to angiotensin II AT1 receptor-transfected [correction of tranfected] Chinese hamster ovary cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884329

13 July 2018

The renin-angiotensin system and its receptors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884329

13 July 2018

Angiotensin II antagonism and plasma radioreceptor-kinetics of candesartan in man

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884329

13 July 2018

Kinetics of pharmacologic response

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884329

13 July 2018

A method for estimating the potency of angiotensin-converting enzyme inhibitors in man.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884329

13 July 2018

The assessment of ACE activity in man following angiotensin I challenges: a comparison of cilazapril, captopril and enalapril

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884329

13 July 2018

The effect of oral cilazapril and prazosin on the constrictor effects of locally infused angiotensin I and noradrenaline in human dorsal hand veins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884329

13 July 2018

Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884329

13 July 2018

Angiotensin II receptor-independent antiinflammatory and antiaggregatory properties of losartan: role of the active metabolite EXP3179.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884329

27 September 2018

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884329

27 September 2018

Angiotensin blockade for hypertension: a promise fulfilled

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884329

27 September 2018

Pharmacodynamic studies on the angiotensin II type 1 antagonists irbesartan and candesartan based on angiotensin II dose response in humans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884329

27 September 2018

Beta adrenoceptor subtype binding activity in plasma and beta blockade by propranolol and beta-1 selective bisoprolol in humans. Evaluation with Schild-plots

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884329

27 September 2018

Hemodynamic responses to angiotensin I in normal volunteers and the antagonism by the angiotensin-converting enzyme inhibitor cilazapril.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884329

27 September 2018

Inhibition of angiotensin-I response by cilazapril and its time course in normal volunteers

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2125.2003.01880.X

21 January 2018

Mechanistic differences of various AT1-receptor blockers in isolated vessels of different origin

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2125.2003.01880.X

21 January 2018

Vasodepressor actions of angiotensin-(1-7) unmasked during combined treatment with lisinopril and losartan

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2125.2003.01880.X

21 January 2018

The relationship between pharmacokinetics and pharmacodynamic action as applied to in vivo pA2: application to the analgesic effect of morphine

1 reference

https://pubmed.ncbi.nlm.nih.gov/12848769

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The pharmacological potency of various AT(1) antagonists assessed by Schild regression technique in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/12848769

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiotensin II receptor blockade with single doses of valsartan in healthy, normotensive subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/12848769

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiotensin II antagonists for hypertension: are there differences in efficacy?

1 reference

https://pubmed.ncbi.nlm.nih.gov/12848769

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of valsartan on the angiotensin II pressor response in healthy normotensive male subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/12848769

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Time course and extent of angiotensin II antagonism after irbesartan, losartan, and valsartan in humans assessed by angiotensin II dose response and radioligand receptor assay

1 reference

https://pubmed.ncbi.nlm.nih.gov/12848769

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insurmountable angiotensin AT1 receptor antagonists: the role of tight antagonist binding

1 reference

https://pubmed.ncbi.nlm.nih.gov/12848769

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacodynamic and pharmacokinetic properties of an angiotensin II receptor antagonist--characterization by use of Schild regression technique in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/12848769

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Receptor binding of propranolol is the missing link between plasma concentration kinetics and the effect-time course in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/12848769

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Theories of drug antagonism

1 reference

https://pubmed.ncbi.nlm.nih.gov/12848769

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of angiotensin II infusion with and without angiotensin II type 1 receptor blockade on nitric oxide metabolism and endothelin in human beings: a placebo-controlled study in healthy volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/12848769

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1046/J.1365-2125.2003.01880.X

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

release_lqzwyuym2fdppe4otxt3qvuf6i

1 reference

https://api.fatcat.wiki/v0/release/lqzwyuym2fdppe4otxt3qvuf6i

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35171866&oldid=1984059906"